Literature DB >> 19224173

6-OHDA induces cycle reentry and apoptosis of PC12 cells through activation of ERK1/2 signaling pathway.

Zhentao Zhang1, Tao Wang, Xuebing Cao, Shenggang Sun, Lan Wang.   

Abstract

This study investigated the effect and mechanism of cell cycle reentry induced by 6-hydrodopamine (6-OHDA) in PC12 cells. By using neural differentiated PC12 cells treated with 6-OHDA, the apoptosis model of dopaminergic neurons was established. Cell viability was measured by MTT. Cell apoptosis and the distribution of cell cycle were assessed by flow cytometry. Western blot was used to detect the activation of extracellular regulator kinase1/2 (ERK1/2) pathway and the phosphorylation of retinoblastoma protein (RB). Our results showed that after PC12 cells were treated wtih 6-OHDA, the viability of PC12 cells was declined in a concentration-dependent manner. Flow cytometry revealed that 6-OHDA could increase the apoptosis ratio of PC12 cells in a time-dependent manner. The percentage of cells in G0/G1 phase of cell cycle was decreased and that in S phase and G2/M phase increased. Simultaneously, ERK1/2 pathway was activated and phosphorylated RB increased. It was concluded that 6-OHDA could induce cell cycle reentry of dopaminergic neurons through the activation of ERK1/2 pathway and RB phosphorylation. The aberrant cell cycle reentry contributes to the apoptosis of dopaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224173     DOI: 10.1007/s11596-009-0121-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  20 in total

Review 1.  Divide and die: cell cycle events as triggers of nerve cell death.

Authors:  Karl Herrup; Rachael Neve; Susan L Ackerman; Agata Copani
Journal:  J Neurosci       Date:  2004-10-20       Impact factor: 6.167

Review 2.  RB, the conductor that orchestrates life, death and differentiation.

Authors:  L Khidr; P-L Chen
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

Review 3.  E2F - at the crossroads of life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Trends Cell Biol       Date:  2008-09-18       Impact factor: 20.808

4.  MAPK-pathway activity, Lrrk2 G2019S, and Parkinson's disease.

Authors:  Linda R White; Mathias Toft; Sylvia N Kvam; Matthew J Farrer; Jan O Aasly
Journal:  J Neurosci Res       Date:  2007-05-01       Impact factor: 4.164

Review 5.  Signaling pathways for PC12 cell differentiation: making the right connections.

Authors:  D Vaudry; P J S Stork; P Lazarovici; L E Eiden
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

6.  Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases.

Authors:  Jian-Hui Zhu; Fengli Guo; John Shelburne; Simon Watkins; Charleen T Chu
Journal:  Brain Pathol       Date:  2003-10       Impact factor: 6.508

Review 7.  The 6-hydroxydopamine model: news from the past.

Authors:  Fabio Blandini; Marie-Therese Armentero; Emilia Martignoni
Journal:  Parkinsonism Relat Disord       Date:  2008-07-02       Impact factor: 4.891

Review 8.  Cell cycle regulation of neuronal apoptosis in development and disease.

Authors:  Esther B E Becker; Azad Bonni
Journal:  Prog Neurobiol       Date:  2004-01       Impact factor: 11.685

Review 9.  The 6-hydroxydopamine model of Parkinson's disease.

Authors:  Nicola Simola; Micaela Morelli; Anna R Carta
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

10.  Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons.

Authors:  D Alvira; M Tajes; E Verdaguer; S García de Arriba; C Allgaier; C Matute; R Trullas; A Jiménez; M Pallàs; A Camins
Journal:  Neuroscience       Date:  2007-03-07       Impact factor: 3.590

View more
  3 in total

1.  Effects of Cymbopogon citratus and Ferula assa-foetida extracts on glutamate-induced neurotoxicity.

Authors:  Ghazaleh S Tayeboon; Fatemeh Tavakoli; Shokoufeh Hassani; Mahnaz Khanavi; Omid Sabzevari; S Nasser Ostad
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-16       Impact factor: 2.416

2.  Oleanolic Acid enhances the beneficial effects of preconditioning on PC12 cells.

Authors:  Babongile C Ndlovu; Willie M U Daniels; Musa V Mabandla
Journal:  Parkinsons Dis       Date:  2014-11-13

3.  Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease.

Authors:  Nian Xiong; Jinsha Huang; Zhentao Zhang; Zhaowen Zhang; Jing Xiong; Xingyuan Liu; Min Jia; Fang Wang; Chunnuan Chen; Xuebing Cao; Zhihou Liang; Shenggang Sun; Zhicheng Lin; Tao Wang
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.